Sylvest Advisors LLC bought a new stake in shares of The Procter & Gamble Company (NYSE:PG - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,245 shares of the company's stock, valued at approximately $544,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Acorn Creek Capital LLC increased its stake in shares of Procter & Gamble by 2.8% during the third quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company's stock valued at $376,000 after buying an additional 59 shares during the period. Patrick M Sweeney & Associates Inc. increased its position in Procter & Gamble by 1.1% during the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company's stock valued at $963,000 after purchasing an additional 59 shares during the period. Traveka Wealth LLC raised its holdings in shares of Procter & Gamble by 1.7% in the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company's stock valued at $616,000 after purchasing an additional 60 shares in the last quarter. Allen Mooney & Barnes Investment Advisors LLC lifted its position in shares of Procter & Gamble by 0.7% in the 3rd quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company's stock worth $1,507,000 after purchasing an additional 61 shares during the period. Finally, Valued Wealth Advisors LLC boosted its stake in shares of Procter & Gamble by 11.2% during the third quarter. Valued Wealth Advisors LLC now owns 605 shares of the company's stock valued at $105,000 after purchasing an additional 61 shares in the last quarter. 65.77% of the stock is owned by institutional investors.
Procter & Gamble Stock Performance
NYSE:PG traded up $2.91 during midday trading on Monday, hitting $168.90. The company's stock had a trading volume of 8,668,582 shares, compared to its average volume of 7,440,821. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55. The Procter & Gamble Company has a fifty-two week low of $153.52 and a fifty-two week high of $180.43. The firm's 50 day moving average is $168.34 and its 200-day moving average is $169.41. The firm has a market cap of $396.05 billion, a P/E ratio of 26.90, a P/E/G ratio of 3.73 and a beta of 0.45.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Wednesday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The firm had revenue of $21.88 billion during the quarter, compared to analysts' expectations of $21.66 billion. During the same quarter last year, the company posted $1.84 earnings per share. The firm's revenue was up 2.1% compared to the same quarter last year. Equities analysts anticipate that The Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be issued a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.38%. The ex-dividend date is Friday, January 24th. Procter & Gamble's dividend payout ratio (DPR) is 64.17%.
Analyst Ratings Changes
A number of equities analysts recently commented on PG shares. UBS Group reduced their price objective on shares of Procter & Gamble from $196.00 to $189.00 and set a "buy" rating for the company in a research note on Thursday, January 16th. Morgan Stanley upped their price objective on Procter & Gamble from $174.00 to $191.00 and gave the stock an "overweight" rating in a research note on Monday, October 21st. Evercore ISI lifted their target price on Procter & Gamble from $180.00 to $183.00 and gave the company an "outperform" rating in a research note on Monday, October 21st. Barclays boosted their target price on shares of Procter & Gamble from $155.00 to $159.00 and gave the stock an "equal weight" rating in a report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. cut their price objective on shares of Procter & Gamble from $186.00 to $181.00 and set an "overweight" rating on the stock in a research report on Thursday, January 16th. Eight equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $180.53.
Check Out Our Latest Research Report on Procter & Gamble
Insider Activity at Procter & Gamble
In related news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the transaction, the insider now owns 11,595 shares in the company, valued at $2,002,804.35. The trade was a 52.47 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the transaction, the chief executive officer now owns 39,977 shares in the company, valued at $7,189,463.68. This represents a 54.48 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 151,097 shares of company stock worth $25,635,076. 0.18% of the stock is owned by corporate insiders.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.